317356-84-6

Basic information

• Product Name: ethyl (2,3-difluoro-4-nitrophenyl)acetate
• Synonyms: ethyl (2,3-difluoro-4-nitrophenyl)acetate
• CAS NO: 317356-84-6
• Molecular Weight: 245.183
• Mol File: 317356-84-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: ethyl (2,3-difluoro-4-nitrophenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl (2,3-difluoro-4-nitrophenyl)acetate(317356-84-6)
• EPA Substance Registry System: ethyl (2,3-difluoro-4-nitrophenyl)acetate(317356-84-6)

Safety Data

• Hazardous Substances Data: 317356-84-6(Hazardous Substances Data)

Upstream product

• 1007572-00-0 C₁₅H₁₇F₂NO₆ 

Downstream Products

• 874974-86-4 C₁₈H₁₃F₃N₂O₅ 
• 1007572-02-2 C₁₇H₁₃BrF₃NO₅ 
• 770718-76-8 C₁₈H₁₅FN₂O₅ 
• 770718-85-9 C₁₈H₁₅FN₂O₅ 
• 770718-93-9 [3-(3-bromo-5-cyano-phenoxy)-2-fluoro-4-nitro-phenyl]-acetic acid ethyl ester 
• 874974-96-6 [3-(3-bromo-5-chloro-phenoxy)-2-fluoro-4-nitro-phenyl]-acetic acid ethyl ester 
• 867366-79-8 C₁₈H₁₂FN₃O₅ 
• 1048979-59-4 C₁₇H₁₂F₂N₂O₅ 
• 770719-10-3 [3-(3-chloro-5-cyanophenoxy)-2-fluoro-4-nitrophenyl]acetic acid ethyl ester 
• 867366-84-5 C₁₈H₁₃F₃N₂O₆ 
• 770718-99-5 [4-Chloro-3-(3-cyano-5-difluoromethyl-phenoxy)-2-fluoro-phenyl]-acetic acid ethyl ester 

Relevant articles and documents

HETEROCYCLIC ANTIVIRAL COMPOUNDS

Compounds of formula I, wherein R1, R2, R3, X1, X2 and Ar, are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC. The present invention also relates to compositions containing compounds of formula I useful for the prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC.

Non-nucleoside reverse transcriptase inhibitors

This invention relates to novel pyridazinone derivatives of formula I wherein R1-R4, R7, R8 and X1 are as defined in the summary and pharmaceutically acceptable salts and solvates thereof, methods to inhibit or modulate Human Immunodeficiency Virus (HIV) reverse transcriptase with compounds of formula I, pharmaceutical compositions containing of formula I admixed with at least one solvent, carrier or excipient and processes to prepare compounds of formula I. The compounds are useful for treating disorders in which HIV and genetically related viruses are implicated